Literature DB >> 16762830

Toll-like receptors and RNA helicases: two parallel ways to trigger antiviral responses.

Etienne Meylan1, Jürg Tschopp.   

Abstract

The early detection by the host of invading microorganisms, including viruses, depends on a limited number of specific receptors that recognize pathogen-associated molecular patterns (PAMPs). A few of these PAMPs, including ssRNA and dsRNA, are recognized by Toll-like receptors (TLR)-7/8 and TLR3, respectively. Activation of an antiviral TLR-dependent signaling cascade leads to the activation of the key transcription factors IRF and NF-kappaB, which promote antiviral responses through induction of specific genes. Recently, a second system has been described, which relies on the cytoplasmic recognition of dsRNA by RNA helicases such as RIG-I. In this review, we discuss the mechanistic aspects of these important arms of the host innate response to dsRNA and a few viral strategies utilized to counteract them.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16762830     DOI: 10.1016/j.molcel.2006.05.012

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  159 in total

Review 1.  Rosacea: The cytokine and chemokine network.

Authors:  Peter Arne Gerber; Bettina Alexandra Buhren; Martin Steinhoff; Bernhard Homey
Journal:  J Investig Dermatol Symp Proc       Date:  2011-12

2.  Pivotal advance: The pattern recognition receptor ligands lipopolysaccharide and polyinosine-polycytidylic acid stimulate factor B synthesis by the macrophage through distinct but overlapping mechanisms.

Authors:  David J Kaczorowski; Amin Afrazi; Melanie J Scott; Joon H Kwak; Roop Gill; Rebecca D Edmonds; Yujian Liu; Jie Fan; Timothy R Billiar
Journal:  J Leukoc Biol       Date:  2010-04-22       Impact factor: 4.962

Review 3.  How tolerogenic dendritic cells induce regulatory T cells.

Authors:  Roberto A Maldonado; Ulrich H von Andrian
Journal:  Adv Immunol       Date:  2010       Impact factor: 3.543

4.  Polyubiquitin conjugation to NEMO by triparite motif protein 23 (TRIM23) is critical in antiviral defense.

Authors:  Kei-ichiro Arimoto; Kenji Funami; Yasushi Saeki; Keiji Tanaka; Katsuya Okawa; Osamu Takeuchi; Shizuo Akira; Yoshiki Murakami; Kunitada Shimotohno
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-19       Impact factor: 11.205

5.  The microRNAs miR-302b and miR-372 regulate mitochondrial metabolism via the SLC25A12 transporter, which controls MAVS-mediated antiviral innate immunity.

Authors:  Kai Yasukawa; Daisuke Kinoshita; Keisuke Yaku; Takashi Nakagawa; Takumi Koshiba
Journal:  J Biol Chem       Date:  2019-11-25       Impact factor: 5.157

6.  Ccr5 regulates inflammatory gene expression in response to encephalomyocarditis virus infection.

Authors:  Benjamin S Christmann; Jason M Moran; Jennifer A McGraw; R Mark L Buller; John A Corbett
Journal:  Am J Pathol       Date:  2011-10-11       Impact factor: 4.307

7.  Increased expression of Toll-like receptor (TLR) 2 and TLR4 in the colonic mucosa of children with inflammatory bowel disease.

Authors:  B Szebeni; G Veres; A Dezsõfi; K Rusai; A Vannay; M Mraz; E Majorova; A Arató
Journal:  Clin Exp Immunol       Date:  2007-11-07       Impact factor: 4.330

Review 8.  Immunogenetics of seasonal influenza vaccine response.

Authors:  Gregory A Poland; Inna G Ovsyannikova; Robert M Jacobson
Journal:  Vaccine       Date:  2008-09-12       Impact factor: 3.641

9.  Induction of alpha/beta interferon by myxoma virus is selectively abrogated when primary mouse embryo fibroblasts become immortalized.

Authors:  Fuan Wang; John W Barrett; Yiyue Ma; Gregory A Dekaban; Grant McFadden
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

10.  Early control of H5N1 influenza virus replication by the type I interferon response in mice.

Authors:  Kristy J Szretter; Shivaprakash Gangappa; Jessica A Belser; Hui Zeng; Hualan Chen; Yumiko Matsuoka; Suryaprakash Sambhara; David E Swayne; Terrence M Tumpey; Jacqueline M Katz
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.